NCT00855959View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Asthma
Interventions
DRUG

Budesonide

Inhalation powder, inhalation, twice daily, 4 weeks followed by Suspension for nebulisation, inhalation, once or twice daily, 6 weeks

DRUG

Pulmicort Turbuhaler

Pulmicort Turbuhaler 200 µg, Dry powder inhaler, budesonide 200 µg/dose, 112 doses/Turbuhaler

Trial Locations (6)

Unknown

Research Site, Ichikawa

Research Site, Yokosuka

Research Site, Chiyoda City

Research City, Hino

Research Site, Setagaya City

Research Site, Tachikawa

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY